Pharmacological management of metabolic syndrome and its lipid complications.

about

Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study Metabolic Syndrome and Neuroprotection.

P2860

Q36845069-B69E32CB-9851-4E3C-B86F-4F3EF5859799 Q53687232-013704B9-C71B-4622-987F-A4F6CB4036DA

P2860

Pharmacological management of metabolic syndrome and its lipid complications.

Item

http://www.wikidata.org/entity/Q35832189

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Pharmacological management of metabolic syndrome and its lipid complications.

@ast

Pharmacological management of metabolic syndrome and its lipid complications.

@en

type

Item

label

Pharmacological management of metabolic syndrome and its lipid complications.

@ast

Pharmacological management of metabolic syndrome and its lipid complications.

@en

prefLabel

Pharmacological management of metabolic syndrome and its lipid complications.

@ast

Pharmacological management of metabolic syndrome and its lipid complications.

@en

P1476

Pharmacological management of metabolic syndrome and its lipid complications.

@en

P2093

Kh Adeli

http://www.w3.org/2001/XMLSchema#string

T Binesh Marvasti

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

DPP-4 inhibitors and their potential role in the management of type 2 diabetes

Gut peptides and type 2 diabetes mellitus treatment.

Minireview: the glucagon-like peptides.

Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.

Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease.

Comparative pharmacology of rosuvastatin.

Beneficial cardiovascular pleiotropic effects of statins.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

P304

146-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22615610

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3304358

http://www.w3.org/2001/XMLSchema#string

Pharmacological management of metabolic syndrome and its lipid complications.

about

P2860

P2860

Pharmacological management of metabolic syndrome and its lipid complications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932